Summary

KEY FINDINGS
The North America 3D bioprinting market growth is anticipated to progress at a CAGR of 16.71% during the forecast period, 2023-2032. Due to the sedentary lifestyles, cardiovascular diseases have a high prevalence in the region. Also, North America houses the highest number of bioprinting manufacturers, including prominent bioprinting vendors like Advanced Solutions and Organovo.
MARKET INSIGHTS
The United States and Canada are assessed for the North America 3D bioprinting market growth analysis. In Canada, favorable government support and rising research & development initiatives contribute to market growth. For instance, the University of British Columbia (UBC) was the first university in Canada to install a 3D printer in a research setting, facilitated by investments from the Natural Sciences and Engineering Research Council of Canada (NSERC). In addition, in May 2021, researchers at the University of Alberta generated customized cartilage for restorative surgeries. This was done by deploying a specially designed hydrogel in combination with cells harvested from patients.
Furthermore, the University of Saskatchewan developed a 3D bioprinted heart patch that can be used to repair and regrow damaged heart tissue. Moreover, researchers at the University of British Columbia, Okanagan, developed a laser bioprinting method that can make live 3D-printed biotissues. Such developments boost the Canada 3D bioprinting market growth.
COMPETITIVE INSIGHTS
Some of the leading companies in the market are CollPlant Biotechnologies Ltd, Allevi, CELLINK, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. EMERGENCE OF 4D BIOPRINTING AS A SUBSTITUTE FOR 3D BIOPRINTING
2.5.2. PERSONALIZED MEDICINE LIKELY TO BOOST 3D BIOPRINTING
2.5.3. RISING INTEREST IN THE APPLICATION OF BIOPRINTING AGAINST THE SARS-COV-2 VIRUS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENTS
3.1.3. RISING FOCUS ON REGENERATIVE MEDICINE
3.1.4. HIGH PREVALENCE OF CHRONIC CONDITIONS
3.2. KEY RESTRAINTS
3.2.1. OPERATIONAL CHALLENGES DURING MANUFACTURING
3.2.2. EXORBITANT COSTS OF 3D BIOPRINTERS
3.2.3. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING IN UNITED STATES
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. DESIGN & SOFTWARE PROVIDERS
4.7.2. PROTOTYPE PRODUCTION
4.7.3. DISTRIBUTION
4.7.4. END-USERS
5. MARKET BY COMPONENT
5.1. 3D BIOPRINTER
5.2. BIOINK
6. MARKET BY BIOMATERIAL
6.1. HYDROGEL
6.2. LIVING CELLS
6.3. EXTRACELLULAR MATRICES
6.4. OTHER BIOMATERIALS
7. MARKET BY TECHNOLOGY
7.1. MAGNETIC LEVITATION BIOPRINTING
7.2. INKJET-BASED BIOPRINTING
7.3. SYRINGE/EXTRUSION-BASED BIOPRINTING
7.4. LASER-ASSISTED BIOPRINTING
7.5. OTHER TECHNOLOGIES
8. MARKET BY APPLICATION
8.1. DRUG TESTING & DEVELOPMENT
8.2. TISSUE ENGINEERING & REGENERATIVE MEDICINE
8.3. FOOD TESTING
8.4. RESEARCH
8.5. OTHER APPLICATIONS
9. MARKET BY END-USER
9.1. HOSPITALS
9.2. BIOPHARMACEUTICALS COMPANIES
9.3. RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
9.4. OTHER END-USERS
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. NORTH AMERICA 3D BIOPRINTING MARKET DRIVERS
10.1.3. NORTH AMERICA 3D BIOPRINTING MARKET CHALLENGES
10.1.4. NORTH AMERICA 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
10.1.5. KEY PLAYERS IN NORTH AMERICA 3D BIOPRINTING MARKET
10.1.6. COUNTRY ANALYSIS
10.1.6.1. UNITED STATES
10.1.6.1.1. UNITED STATES 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
10.1.6.2. CANADA
10.1.6.2.1. CANADA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.2. COMPANY PROFILES
11.2.1. 3D BIOPRINTING SOLUTIONS
11.2.1.1. COMPANY OVERVIEW
11.2.1.2. PRODUCTS LIST
11.2.2. ADVANCED SOLUTIONS LIFE SCIENCES
11.2.2.1. COMPANY OVERVIEW
11.2.2.2. PRODUCTS LIST
11.2.3. ALLEVI
11.2.3.1. COMPANY OVERVIEW
11.2.3.2. PRODUCTS LIST
11.2.4. CELLINK
11.2.4.1. COMPANY OVERVIEW
11.2.4.2. PRODUCTS LIST
11.2.4.3. STRENGTHS & CHALLENGES
11.2.5. COLLPLANT BIOTECHNOLOGIES LTD
11.2.5.1. COMPANY OVERVIEW
11.2.5.2. PRODUCTS LIST
11.2.6. CYFUSE BIOMEDICAL KK
11.2.6.1. COMPANY OVERVIEW
11.2.6.2. PRODUCTS LIST
11.2.6.3. STRENGTHS & CHALLENGES
11.2.7. ENVISIONTEC ṁ INC
11.2.7.1. COMPANY OVERVIEW
11.2.7.2. PRODUCTS LIST
11.2.7.3. STRENGTHS & CHALLENGES
11.2.8. GESIM GMBH
11.2.8.1. COMPANY OVERVIEW
11.2.8.2. PRODUCTS LIST
11.2.8.3. STRENGTHS & CHALLENGES
11.2.9. INVENTIA LIFE SCIENCE PTY LTD
11.2.9.1. COMPANY OVERVIEW
11.2.9.2. PRODUCTS LIST
11.2.10. ORGANOVO HOLDINGS INC
11.2.10.1. COMPANY OVERVIEW
11.2.10.2. PRODUCTS LIST
11.2.10.3. STRENGTHS & CHALLENGES
11.2.11. REGEMAT 3D
11.2.11.1. COMPANY OVERVIEW
11.2.11.2. PRODUCTS LIST
11.2.11.3. STRENGTHS & CHALLENGES
11.2.12. REGENHU
11.2.12.1. COMPANY OVERVIEW
11.2.12.2. PRODUCTS LIST
11.2.12.3. STRENGTHS & CHALLENGES
11.2.13. REVOTEK CO LTD
11.2.13.1. COMPANY OVERVIEW
11.2.13.2. PRODUCTS LIST
11.2.14. ROKIT HEALTHCARE INC
11.2.14.1. COMPANY OVERVIEW
11.2.14.2. PRODUCTS LIST
11.2.15. STRATASYS LTD
11.2.15.1. COMPANY OVERVIEW
11.2.15.2. PRODUCTS LIST